Obviously, only a case control study could assess if the higher prevalence of carotid atherosclerosis observed in NAFLD [2] compared to individuals without steatosis, is related to an higher prevalence of PNPLA3 genotype and risk of cardiovascular disease. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.